EUVIMEDEUVIMED entdecken
Crossref

Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States

Nishant Uppal iD, Zirui Song iD

New England Journal of Medicine · 2024

DOI: 10.1056/nejmp2400608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Nishant Uppal und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine, Brigham and Women's Hospital (N.U.), the Department of Health Care Policy and the Center for Primary Care, Harvard M…. Hauptthemen laut MEDLINE: Commerce, Private Sector, Health Care Sector. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CommercePrivate SectorHealth Care SectorHumansUnited StatesPublic Sector

Autor:innen und Institutionen

  • From the Department of Medicine, Brigham and Women's Hospital (N.U.), the Department of Health Care Policy and the Center for Primary Care, Harvard Medical School (Z.S.), and the Department of Medicine, Massachusetts Ge…

ORCID-Profile: Nishant Uppal, Zirui Song

Zitieren

APA

Uppal, N., & Song, Z. (2024). Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States. New England Journal of Medicine. https://doi.org/10.1056/nejmp2400608

Vancouver

Uppal N, Song Z. Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States. New England Journal of Medicine. 2024. doi:10.1056/nejmp2400608

BibTeX
@article{Uppal2024,
  author = {Uppal, Nishant and Song, Zirui},
  title = {Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmp2400608}
}
Kostenlos starten →